SMAD2 and intrahepatic cholangiocarcinoma: The activation of these two pathways in IH-ICC were further validated by the translocation of phopho-SMAD2/3 and zinc finger GLI1 as shown in immunofluorescence staining (Fig. 7E and Supplementary Fig. 21).